Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease

BACKGROUND: We examined a large community‐based sample of patients with atrial fibrillation (AF) and valvular heart disease (VHD) (excluding prosthetic valves) with a goal to compare outcomes among patients with AF, with and without VHD, taking warfarin, dabigatran, and rivaroxaban. METHODS AND RESU...

Descripción completa

Detalles Bibliográficos
Autores principales: Briasoulis, Alexandros, Inampudi, Chakradhari, Akintoye, Emmanuel, Alvarez, Paulino, Panaich, Sidakpal, Vaughan‐Sarrazin, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015407/
https://www.ncbi.nlm.nih.gov/pubmed/29622591
http://dx.doi.org/10.1161/JAHA.118.008773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015407/
https://www.ncbi.nlm.nih.gov/pubmed/29622591
http://dx.doi.org/10.1161/JAHA.118.008773

Ejemplares similares